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Venous thoracic outlet syndrome progressing to the point of axilosubclavian vein thrombosis, variously referred to as
Paget-Schroetter syndrome or effort thrombosis, is a classic example of an entity which if treated correctly has minimal
long-term sequelae but if ignored is associated with significant long-term morbidity. The subclavian vein is highly
vulnerable to injury as it passes by the junction of the first rib and clavicle in the anterior-most part of the thoracic outlet.
In addition to extrinsic compression, repetitive forces in this area frequently lead to fixed intrinsic damage and extrinsic
scar tissue formation. Once primary thrombosis is recognized, catheter-directed thrombolytic therapy is usually
successful if initiated within ten to 14 days of clot formation, but often unmasks an underlying lesion. The vast majority
of investigators believe that decompression of the venous thoracic outlet, usually by means of first rib excision, partial
anterior scalenectomy, resection of the costoclavicular ligament, and thorough external venolysis, is necessary, although
opinion is less uniform as to the need for and method of treatment of the venous lesion itself. Using this algorithm,
long-term success rates of 95 to 100% have been reported by many investigators. This review, in addition to discussing
the overall treatment algorithm in more detail, attempts to point out controversies that still exist and research directions,
both clinical and basic, that need to be pursued. Prospective randomized trials addressing this entity are surprisingly
lacking, and although there is consensus based on experience, it may be necessary to step back and rigorously explore
several aspects of this entity. ( J Vasc Surg 2010;51:1538-47.)Paget-Schroetter syndrome, also referred to as “ef-
fort thrombosis,” refers to primary thrombosis of the
subclavian vein at the costoclavicular junction. Sir James
Paget1 was the first to describe a case of “gouty phlebi-
tis” of the upper extremity in 1875, which turned out to
be spontaneous thrombosis of the subclavian vein, and
von Schroetter2 postulated in 1884 that this entity re-
sulted from direct damage to the vein caused by stretch-
ing that occurred from muscular strain. The English
surgeon, Hughes,3 termed the condition Paget-von
Schroetter syndrome in 1949, and it has been known by
variations of this eponym ever since.
A surprising amount of confusion surrounds thoracic
outlet syndrome (TOS) in general, due in part to the
mistaken assumption that this is all one entity. There are
two different and distinct anatomic spaces to consider –
the brachial plexus and subclavian artery pass through
the triangle formed by the scalenus anticus and medius
muscles and the first rib, whereas the subclavian vein
re-enters the chest more anteriorally, passing adjacent to
the junction of the clavicle and first rib which is further
reinforced by the subclavius muscle and tendon (Fig 1). In
order of incidence, neurogenic (NTOS), venous (VTOS),
From the Department of Surgery, Division of Vascular Surgery, University
of Rochester Medical Center.
Competition of interest: none.
Reprint requests: Karl A. Illig, MD, Professor of Surgery and Neurosurgery,
University of Rochester Medical Center, Division of Vascular Surgery,
601 Elmwood Ave, Box 652, Rochester, NY 14642 (e-mail: karl_illig@
urmc.rochester.edu).
The editors and reviewers of this article have no relevant financial relationships
to disclose per the JVS policy that requires reviewers to decline review of any
manuscript for which they may have a competition of interest.
0741-5214/$36.00
Copyright © 2010 by the Society for Vascular Surgery.
doi:10.1016/j.jvs.2009.12.022
1538and arterial (ATOS) thoracic outlet syndromes are three
distinct entities and should be conceptualized, discussed,
analyzed, and treated as such. VTOS is further divided into
three different categories: intermittent/positional venous
obstruction, secondary subclavian vein thrombosis (in the
setting of catheters or pacemaker leads), and primary “ef-
fort thrombosis” (Fig 2). The last entity, primary effort
thrombosis, is the topic of the current review.
Essentially, no prospective randomized trials concern-
ing the treatment of effort thrombosis exist; most of what
we do today is guided by single series reports, retrospective
reviews, expert opinion, book chapter, and general review
articles (for example, Swinton et al4 [1968] for an early
overview, Shebel and Marin5 [2006] for a very readable
review presented to vascular nurses, and Landry and Liem6
[2007] for a recent endovascular update). At this point in
time, we feel that certain areas are well-established by
consensus, but point out that prospective randomized trials
are sorely needed. This review will discuss the evolution of
treatment for this entity over the past half century (from
heparinization alone to catheter-based thrombolysis fol-
lowed by thoracic outlet decompression), review current
management schemes, and attempt to summarize modern
consensus opinion. We will also provide a list of needed
data – what needs to be done to better guide our care of
these patients?
EPIDEMIOLOGY, ANATOMY, AND
PATHOPHYSIOLOGY
Primary effort thrombosis seems to be a relatively rare
condition. The incidence has been extrapolated from a
Swedish experience to be about 2.03 per 100,000 people
per year,7 whereas even as a regional referral center, we have
seen only 1.0 patients per 100,000 population per year over
the past 5 years. If the true incidence is between one and
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United States would be 3000 to 6000 cases yearly. Upper
extremity effort thrombosis accounts for approximately 1%
to 4% of all episodes of venous thrombosis,8,9 which yields
a slightly higher estimate. Like many “rare” problems, its
incidence is likely under-recognized by nonspecialists.
Mean age at presentation is the early 30s, and the male
to female ratio is approximately 2:1. It is more common on
the right, likely because of the incidence of right-hand
dominance, and 60% to 80% of patients report a history of
vigorous exercise or activity involving the upper extremi-
ties.7,10-12 A recent review of one major league and one
division I baseball team over an 11-year period revealed 4
such cases, which yields a rate of 1 case every 5 years per
high-level baseball club, for example.13
The relative rate of primary effort thrombosis vs sec-
ondary thrombosis is difficult to identify, as no comprehen-
sive studies have been performed. Two surveys of all epi-
sodes of upper extremity thrombosis at each of two
institutions suggest that the ratio is close to 40%,11,14
although both series are small.
Anatomy and pathophysiology. VTOS is a disorder
of the anterior part of the thoracic outlet region, where the
subclavian vein passes by the intersection of the clavicle and
first rib (Fig 1). Whereas the posterior/cephalad portion of
this area is open (the anterior scalene, lying posterior to the
vein, does not communicate with the clavicle), a hypertro-
phied anterior scalene can compress the vein from behind.
In addition, the subclavius muscle itself underlying the
Fig 1. Basic anatomy of the thoracic outlet. The subclavian/
axillary vein is located anteriorally, and passes in front of the
anterior scalene muscle (shown detached from its origination on
the spine). Note the position of the vein between the first rib and
clavicle, the position of the subclavius tendon, and the potential for
“nutcracker-like” compression by the two bones, even with only
minimal movement. m, Muscle; v, vein.clavicle and providing “bulk” at the costoclavicular junc-tion can further compress this area. Although the first rib
and clavicle don’t move very much, they do so with extreme
force and leverage – and the vein is located precisely at the
point of maximal compression. It is unclear whether an
anatomically smaller costoclavicular space, resulting from
either hypertrophied muscle (scalenus anterior or subcla-
vius) or abnormal bone morphology (clavicle or first rib) is
required or whether this condition can simply occur with-
out a defined abnormality.
Adams et al15 demonstrated that even in normal pa-
tients the subclavian vein can easily be compressed within
the costoclavicular space (Fig 3). Regardless of which ana-
tomic structure is thought to be abnormal, the subclavian
vein is compressed with arm abduction by any one structure
alone or in combination.16-19
In our experience, when vigorous activity cannot be
elicited, maneuvers where the arm is frequently overhead
(auto repair, painting, recreational badminton, and weight
training) is often present, and we have seen several recent
cases in teenaged baseball pitchers and teenaged swimmers.
A history of clavicle fracture is not uncommon, although
the presence of a cervical rib (a relatively posterior struc-
ture) is not felt to be a risk factor for VTOS. Forty percent
of patients recall an activity that involves repetitive or
prolonged hyperabduction or external rotation of the
shoulder joint,20,21 and at times no factor other than
increased muscle bulk can be elicited.
It is unclear whether thrombosis results from a single
insult or is the result of the cumulative effects of chronic
injury to this area. It is thought that chronic compression
and trauma eventually produce external inflammation,
which in turn leads to fibrosis, relative fixation to the
surrounding anatomic structures, and perhaps intimal hy-
pertrophy.22 It is clearly seen at operation that the loose
connective tissue which normally surrounds the vein is
replaced by dense collagen scar. This scar-entrapped vein
becomes less mobile as it traverses the costoclavicular space
and, therefore, becomes at increased risk for further injury.
Because the vein is no longer able to freely move in this
area, it is stretched and torn whenever the diameter of the
costoclavicular space is changed.
Some patients are thought to have intermittent ve-
nous outflow obstruction caused by compression in this
area without objective evidence of actual injury to the
vein. These patients will have venograms that are normal
at rest but abnormal (varying degrees of extrinsic com-
pression with “new” venous collaterals) with the arm
abducted (Fig 3, A, B). The natural history of these
patients is unclear, but they are thought to be at risk for
later thrombosis and are often electively treated. Alter-
natively, a subclinical syndrome may develop wherein
there is recurrent partial thrombosis followed by recan-
alization,15,23 with or without symptoms. Each time the
vein is partially thrombosed and recanalized, the se-
quence of local inflammation and further scar formation
progressively add to the intrinsic venous defects; the
presence of collagen webs and fibroelastic strictures
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exploration, is not uncommon.
Whatever the mechanism, when the vein fully occludes
symptoms are almost always present and, if thrombosis is
sudden and complete, severe. Multiple collateral pathways
exist, termed by Adams et al19 “first-rib bypass collaterals,”
most notably connecting cephalic vein and profunda branches
with the transverse cervical, scapular, and external and
internal jugular veins. These collateral pathways, in addi-
tion to providing drainage from the arm, are extremely
valuable diagnostic venographic clues that a hemodynamic
obstruction exists even if not well seen itself, but are not
usually adequate to provide full drainage and obviate symp-
toms. Typically the early thrombus is soft and easily treated,
whereas chronically (over weeks) it becomes organized,
adherent, and fibrotic. In extreme cases, the vein can fibrose
to a solid lumenless cord. Although a report from Sweden
published in 19887 suggested that hypercoagulable states
are relatively infrequently seen, a more recent investigation
suggested that the rate of any hypercoagulable condition
may be as high as 67%.24
CLINICAL PRESENTATION
Patients with intermittent positional venous obstruc-
tion will present with episodic arm discoloration and swell-
ing, usually elicited by either exercise or arm elevation. By
contrast, those with true effort thrombosis will almost
always be persistently and, if acutely thrombosed, severely
symptomatic. Clinical presentation is classic, with the pa-
tient complaining of a blue, swollen, heavy, painful arm.
Patients typically present with sudden onset of an aching
Fig 2. Basic classification of thoracic outlet syndrome
precursor of effort thrombosis if not recognized and trea
their relative frequencies are shown, most common to
syndrome.discomfort with a feeling of heaviness, swelling, and fre-quently a reddish-blue discoloration of the affected upper
extremity. Sixty to 80% of patients report a history of
vigorous exercise or activity involving the upper extrem-
ities, and approximately 85% of patients will have symp-
toms within 24 hours of the inciting event. A prominent
venous pattern consisting of dilated superficial collateral
veins over the upper arm, base of the neck, and anterior
chest wall develops in many patients, especially if occlu-
sion is chronic.5,8,10,12,25,26
The diagnosis is usually straightforward. A duplex ul-
trasound scan is diagnostic, with high accuracy in experi-
enced hands. In a recent randomized trial, for example, a
duplex scan was found to have a sensitivity of 78% to 100%
and a specificity of 82% to 100%.27 At times, positional
stress can help, but in true effort thrombosis by definition
the vein is thrombosed at rest, so examining the arm in a
neutral position is usually adequate. As seen during any
duplex venographic evaluation for clot, a fresh thrombus,
although echolucent, will be apparent by lack of compress-
ibility and absence of flow, whereas a more chronic clot will
be more fibrotic and echogenic. An experienced technician
can often also visualize the prominent collateral venous
pathways that develop. Potential drawbacks include the
inability to adequately visualize the central portions of the
subclavian and innominate veins and difficulty in differen-
tiating a central vein from a large collateral. In a recent
imaging consensus statement published by the American
College of Radiology,28 an ultrasound scan was felt to be
the best first approach for direct evaluation of arm veins,
whereas venography, for example, was recommended if
noninvasive studies are inconclusive (or intervention is
rmittent positional venous obstruction is felt to be a
he exact incidences of these conditions is unknown, but
common, reading left to right. TOS, Thoracic outlet. Inte
ted. T
leastplanned).
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when used in the evaluation of TOS in general, probably
because no gross or categoric structural abnormality usually
exists. MR and CT are increasingly useful to examine the
central veins,28 but no investigator has been able to identify
bony and/or soft tissue abnormalities that affect treatment
in this situation. We have recently experimented with CT
and MR “venograms” to assess central venous inflow in
difficult dialysis access patients, but have been discouraged
by the inability to visualize the venous structures at the
costoclavicular junction with adequate resolution. In addi-
tion, because history, physical examination, and duplex
ultrasound scans are so reliable and venography essentially
always follows this diagnosis, the benefit of further axial
imaging is unclear.
Venography is both diagnostic and often therapeutic.
Diagnostic venography can be performed via relatively dis-
tal access of a peripheral vein, although if visualization is
suboptimal or if intervention is planned, ultrasound scan-
Fig 3. Effect of arm position on the axillary/subclavian vein at
the costoclavicular junction. A, Arm outstretched but less than 90
degrees. Note the absence of obstruction and the absence of
collaterals. B, Arm abducted well over 90 degrees. Note the
smooth extrinsic compression at the costoclavicular junction and
the visualization of the external jugular vein and surrounding
collaterals.guided access to the deep system (true brachial veins) at theantecubital fossa or distal upper arm is needed. As pointed
out by Green and Rosen,29 the diagnosis can be missed if
the upper arm cephalic vein is used for contrast injection.
The diagnosis should be immediately obvious by noting
occlusion of the subclavian vein at the costoclavicular junc-
tion (at times with more distal extension of thrombus) and
by the presence of collaterals, which will not be visualized if
axial flow is normal. If the vein seems open but collaterals
are present, some degree of obstruction must exist (Fig 4),
and if the vein is open and no collaterals are seen the arm
must be abducted to well over 90 degrees with a normal
venogram before VTOS is ruled out. If the deep system is
nonvisualized and the venogram is otherwise normal, the
study should be repeated with a tourniquet in place to
occlude the superficial venous system (although it should
be pointed out that the problem lies central to the normal
confluence of the cephalic vein into the axillary-subclavian
system).
TREATMENT
The treatment of effort thrombosis has been the subject
of a surprising volume of literature over the past half
century, perhaps in disproportionate volume to its inci-
dence. The central issues are whether this should be treated
at all, the best method of treatment of the thrombus itself,
timing and method of “permanent” correction of the un-
derlying defect, and how to treat and follow these patients
in the long term.
Natural history and anticoagulation alone. It was
recognized as early as a 1949 report30 that leaving this
condition untreated results in significant morbidity in the
majority of patients, and once anticoagulation became
available this became the earliest standard of care. Results
with anticoagulation alone, however, are quite poor. For
Fig 4. Venogram in a patient after thrombolysis with significant
residual obstruction. Note that although the obstruction itself is
poorly visualized, extensive venous collaterals are present. These
are pathognomonic for a hemodynamically significant obstruction
to outflow.example, acute pulmonary embolism occurs in 6% to 15% of
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treated effort thrombosis causes residual upper extremity
venous obstruction in up to 78% of cases, whereas persis-
tent symptoms and permanent disability are present in 41%
to 91% and 39% to 68% of such patients, respectiv-
ely.11,12,21,30-32,34 Heron et al35 reported “negligible”
symptoms at follow-up in only 25 of 54 patients (46%) so
treated, whereas in a more modern review Urschel et al20
reported “excellent or good” long-term results in only 10
of 35 patients (29%) treated with anticoagulation (with first
rib resection reserved for persistent problems) alone.
Thrombolytic therapy. Because of the disappointing
long-term outcomes after anticoagulation alone, catheter-
directed thrombolysis has become the standard first step in
all patients with acute effort thrombosis unless significant
contraindications are present. Apparently, first performed
in the late 1970s, the first reports of such were published in
the early to mid 1980s by Zimmerman et al,36 Becker et
al,37 Taylor et al,38 Druy et al,39 and Perler and Mitchell,40
with encouraging, albeit uncontrolled results.
Machleder, in a seminal 1993 paper, described the
results of a structured algorithm introduced at UCLA in
1985, which consisted of thrombolysis and selective first rib
resection after approximately 3 months’ delay to “avoid
rethrombosis.” Although 50 patients were treated by this
protocol, only 43 had thrombolysis and 36 thoracic outlet
decompression. A total of 93% of patients who were left
with an open vein were free of symptoms at follow-up,
whereas only 64% of those whose veins could not be
reopened were free of symptoms.41
Catheter-directed thrombolysis is successful in 62% to
84% of cases,14,42 although this rate is much higher the
fresher the clot, nearing 100% if initiated within a few days
of symptom onset. In three recent reports, no patient with
symptoms persisting for longer than 10 days had successful
lysis,36,43,44 whereas the success rate in patients at the
University of Rochester with symptoms of less than 14
days’ duration has been 84% over the past decade.42 In a
large experience from Baylor, only 50% of occluded veins
could be partially opened if treated more than 6 weeks after
symptom onset; none were completely recanalized.20 A
greater clot burden also correlates negatively with success;
Molina45 and Green and Rosen22 report 25% and 22%
success rates in “long segment” occlusions, respectively.
After thrombolysis, a significant number of patients are
shown to have intrinsic venous defects45,46 caused by scar-
ring due to persistent injury and essentially all will have
extrinsic compression at the costoclavicular junction. If
surgical decompression is not performed, rethrombosis
within 30 days has been reported to occur in as many as a
third of patients.20,39,47,48 Angioplasty and even stenting
of these patients is tempting, but the costoclavicular junc-
tion is unyielding, and angioplasty before decompression
fails at high rates.41,49-51 It has been suggested (but not
proved) that predecompression angioplasty may even di-
rectly worsen venous patency by further damaging the
endothelium.52,53 Stenting of the vein running through
the nondecompressed costoclavicular junction has beenshown to be complicated by stent fracture in some, defor-
mation in nearly all, and rethrombosis rates as high as
40%.49 Stents in this location, whether fractured or not,
obviously complicate subsequent repair, and for this reason
as well should be avoided at all costs. It is essential to
remember that the force of the costoclavicular junction far
overwhelms the strongest stent.
Correcting the problem. Thrombosis is only the
acute symptom of the underlying chronic problem, which is
extrinsic compression and internal damage to the vein at
the costoclavicular junction. Thrombolysis treats the im-
mediate complication, but clot will recur and symptoms
persist in as many as a third of patients whose underlying
anatomic problem is not corrected.20,39,47,48 It is generally
accepted that surgical decompression of the costoclavicular
junction should follow thrombolysis, but recommenda-
tions, dogma, and beliefs vary widely according to whether
lysis is complete, whether intrinsic venous defects persist,
and the degree of residual symptoms. In addition, signifi-
cant differences exist regarding both methods and timing
of decompression, and a respected minority view, discussed
below, holds that decompression may not be necessary
at all.
Transaxillary first rib resection, first reported by Roos in
1965,54 is the most common method of doing so. The
major advantage of this method is that it offers excellent
exposure of the anterior portion of the first rib where the
pathology exists with excellent cosmesis. It is technically
challenging, however, and complications, which can in-
clude hemopneumothorax and long thoracic nerve injury,
are not trivial; a “complication” unusual to this procedure
in inexperienced hands is removal of the second rib instead
of the first by mistake. Results are generally favorable:
Urschel and colleagues in sequential evaluations of their
experience report “good to excellent long-term results” in
85% to 95% of their patients so treated.55 We and oth-
ers56,57 emphasize two technical points: the subclavius
tendon at the costoclavicular junction and muscle separat-
ing the vein from the clavicle should be aggressively de-
bulked, and second, the fibrotic tissue surrounding the vein
should be resected after the bone and muscles are out. The
vein can safely be circumferentially freed to the level of the
jugular vein in most cases. It should be noted that although
this venolysis has not been extensively emphasized in the
literature most clinicians with large VTOS practices feel this
is an intrinsic part of the repair.
Decompression of the costoclavicular junction can also
be performed by various combinations of supra-, para-, and
infraclavicular first rib resection52,58-60 (advantages: best
visualization of critical structures and access for reconstruc-
tion; disadvantages: two incisions may be required for full
removal of the anterior part of the first rib), sternal disar-
ticulation with first rib resection61,62 (advantage: excellent
visualization of the costoclavicular junction; disadvantage:
healing is not assured and morbidity if so significant), and
medial claviculectomy63 (advantage: most complete expo-
sure of the vein; disadvantage: cosmetics and perceived
mechanical drawbacks of claviculectomy). Whatever ap-
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anterior first rib and/or medial clavicle must be addressed
and the vein freed from surrounding fibrotic tissue and
mobilized.
It should be noted that a significant dissenting opinion
exists regarding the necessity to decompress the bony tho-
racic outlet at all. Kaj Johansen describes a series of 50
patients with primary effort thrombosis undergoing throm-
bolysis who were then anticoagulated and observed, but
did not undergo surgery. At a mean follow-up of 57
months, 82% were entirely asymptomatic, and another 10%
had only mild symptoms.64 He argues that decompression
is based on relatively old data (1980s-2000) in patients not
undergoing thrombolysis, and quotes symptom-free rates
of 83% to 90% (with one outlying study reporting
96%).65,66 A recent study from Stanford, however, showed
a 23% recurrence rate in patients initially managed nonop-
eratively,51 and his own series demonstrated an 18% occlu-
sion rate with another 24% of patients having stenoses
greater than 50%.64 These results must be compared to
those of Urschel and Razzuk,20 who showed (in 2000) a
95% rate of excellent or good outcomes in 199 patients
treated with thrombolysis and first rib resection over a
20-year period and Molina et al,67 who showed (in 2007) a
100% patency and 0% rate of significant symptoms at 5 years
after thrombolysis and first rib resection for acute effort
thrombosis. It is fair to say that the data suggest that a
prospective randomized trial to address this issue is not
unreasonable, but modern results of thrombolysis followed
by surgical first rib resection in the proper hands are superb.
Timing of decompression. Although substantial
consensus exists that the costoclavicular junction must be
decompressed to prevent recurrence, less agreement as to
timing of this decompression is present. Based initially on
theoretical concerns and examination of venous endothe-
lium and function after thrombosis53 and the perceived
risks of operation soon after thrombolysis, the UCLA
group led by Herb Machleder established the precedent of
waiting 3 months for decompression.41,68 Results in a
rather heterogeneous group of patients were good, with
83% of patients undergoing both lysis and thoracic outlet
decompression being free of symptoms in their 1993 re-
port.41 In a 2005 series of 71 patients undergoing staged
decompression after thrombolysis at the University of
Michigan, 90% returned to work.69
The problem with this strategy is that rethrombosis can
occur in 10% or more of patients in the interval41 and that
this strategy delays definitive correction of the problem and
return to premorbid status with interval disability.70 Mul-
tiple series and descriptions now exist of patients undergo-
ing immediate thoracic outlet decompression after throm-
bolysis which demonstrate excellent results and reasonably
low complication rates.20,42,52,58,60,70-72
Urschel and colleagues71 working at the University of
Texas Southwestern/Baylor were early proponents of op-
erative decompression immediately after thrombolysis. In a
1991 review of their experience with 67 patients treated
over 25 years, they reported that the last 33 patients weretreated with “early” first rib resection after thrombolysis,
with good results.71 They updated their experience in
2000, describing extremities treated with thrombolysis fol-
lowed by “prompt” first rib resection (defined as “generally
the next day” in the discussion). In the 199 extremities
treated within 6 weeks of the onset of symptoms, 189
(95%) had excellent or good results whereas only two had
poor results, and no recurrences were observed.20 Azakie et
al58 and Lee et al52 noted similar good results in smaller
groups of patients, and the latter specifically stressed that
early decompression had both medical and employment
advantages. In 2007, Molina et al67 described immediate
subclavicular first rib decompression after thrombolysis in
97 patients with only one bleeding complication.
Results were persuasive enough that by the late 1990s
the UCLA group shifted to this policy of early thoracic
outlet decompression, reporting their early experience with
this new protocol in 2000. Although comparing only 9
patients in each group, the “early” group (mean delay 3
days, though ranging up to 15) had the same blood loss and
overall outcome than the “staged” group (mean, 87 days;
range, 42-125). No patient had a surgical complication or
required transfusion, and all patients had “resolution of
symptoms” and returned to work or avocation.70 At
present, it is fair to say that although prospective compari-
son will be needed to definitively answer this question,
immediate decompression after thrombolysis has been
shown to be safe with regard to historic complication rates
and very effective overall, and probably returns the patient
to their premorbid status earlier.
Treatment of residual intrinsic defects. In many
cases, significant intrinsic defects are seen in the vein after
lysis of all possible thrombus and full surgical venolysis.
Assuming the extrinsic problem is addressed by costocla-
vicular decompression, several schools of thought regard-
ing treatment of intrinsic residual venous defects exist. First
is to leave this alone (and anticoagulated). Proponents of
this approach stress the high failure rates of angioplasty and
stenting in the undecompressed venous thoracic outlet and
the endothelial damage that even balloon angioplasty cre-
ates, and point out that many or most such lesions will
remodel with time once bony decompression and venolysis
has taken place.56 Another approach is to perform delayed
venography and balloon venoplasty after allowing several
weeks for the endothelium to recover from the insult of
thrombosis and thrombolysis, whereas a third is to perform
immediate balloon venoplasty and even stenting at the time
of bony decompression. Kreienberg et al73 described the
performance of balloon venoplasty alone in 9 patients and
stenting in another 14 patients immediately after decom-
pression. Interestingly, patency was 100% at 4 years in the 9
patients undergoing angioplasty alone, but only 64% at 3.5
years in the 14 who required stenting. Although they
identified several factors worsening results of stenting ap-
parently independent of the stent itself, this difference is
interesting. At present, it seems fair to say that evidence
does exist that stents in this situation, even if the costocla-
vicular joint has been decompressed, may have a worse
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postdecompression balloon angioplasty and observation
alone for residual postlytic intrinsic defects both yield good
long-term results.
The role of venous reconstruction. A third major
question is when to reconstruct the vein in situations where
significant intrinsic lesions persist. Thompson advocates a
fairly aggressive approach to reconstruction, using it when
external venolysis is unsuccessful,60,74 often with a tempo-
rary arteriovenous (AV) fistula, as do Molina and oth-
ers.67,75 We advocate reserving reconstruction for those in
whom significant hemodynamic effects persist, defined as
persistent and significant symptomatology, despite bony
decompression, external venolysis, and balloon angio-
plasty, and have observed a 94% patency rate in the most
severe group of chronic occlusions treated with medial
claviculectomy in combination with venous reconstruc-
tion.42 Jugular vein turndown76 is an excellent option in
this situation, allowing removal of all diseased endothelium
from the flow channel, but direct reconstruction as advo-
cated by Thompson also shows durable results. We believe
that jugular turndown and reconstruction are best per-
formed with the direct vision allowed by claviculectomy,63
but good results can be achieved leaving it in place in
certain circumstances.60,77 At present, all results of the
various reconstructive procedures are anecdotal.
Total occlusion. Finally, there is a subset of patients
who remain totally occluded after attempts at thrombolysis.
We believe that such patients should be treated identically
to those with residual defects; that is, based on symptom
status. It has been shown that recanalization can occur in
this situation. De Leon documented 4 patients with total
occlusion who underwent thorough bony decompression
who recanalized at a mean of 7 months after surgery with
good symptom relief.78 Once the venous thoracic outlet
has been decompressed, symptom status should be as-
sessed. If the patient is functional, observation and anticoag-
ulation is probably best to allow recanalization or collateral
maturation, although if symptoms are severe, reconstruction
(usually by means of jugular vein turndown because the
cord-like residual vein is not otherwise reconstructable) is
carried out.
Postoperative care. All agree that these patients
should be anticoagulated, although no data exist as to
timing. Most agree, however, that as the extrinsic problem
has been corrected and the incidence of hypercoagulable
syndromes is low, anticoagulation can be temporary. We
use a 6-month window based on the treatment of deep vein
thrombosis (and because 2 of our patients whose Couma-
din was stopped before this time rethrombosed), although
many report limiting anticoagulation to 3 months. We
perform examination and ultrasound at 1 and 6 months
after surgery with yearly visits after, and instruct patients to
contact us immediately if symptoms recur. The rate of
contralateral effort thrombosis or venous symptomatology
in these patients, although not zero, seems to be low based
on clinical symptomatology, although rates of thrombosis
and compression when studied venographically have beenshown to be as high as 15% to 70%.79,80 Recurrence rates
are very poorly documented in the literature, but may be
inferred to be low by the relative absence of such reports.
OUTCOME
As might be expected from a large number of relatively
uncontrolled single-center series reporting on outcomes of
patients treated in a variety of different ways over many
years, outcome data are very difficult to describe. Based on
the data presented and cited above, the authors would
suggest that good results may be expected in only 50% to
66% of patients treated with anticoagulation alone (with or
without rib resection), in 80% to 90% of patients treated
with thrombolysis and delayed thoracic outlet decompres-
sion, and in 90% to 95% of patients diagnosed quickly and
treated with thrombolysis and immediate decompression.
The one objective study of this issue was recently
published by Chang et al,81 who studied 26 patients seen at
Johns Hopkins for venous TOS over a 3-year period using
validated quality of life survey instruments. Only 77% of
such patients returned to work, although another 2 re-
turned to part-time employment and the statistical treat-
ment of students and those unemployed before their illness
was unclear. Patients with VTOS seemed to be fully recov-
ered by 1 year after their operation.
SUGGESTED TREATMENT ALGORITHM
Fig 5 presents the treatment algorithm we suggest
based on our observations and the existing literature, mod-
ified somewhat from Doyle et al.42
When a patient presents with effort thrombosis (or
symptomatic partial intrinsic obstruction), the duration of
symptoms (hence urgency of initiation of treatment) is the
most critical factor. In all cases, diagnostic venography
should be performed. If symptoms have been present for
more than 14 days, wire passage can be attempted, but
thrombolysis is unlikely to be successful. If symptoms have
been present for less than 14 days, thrombolysis is more
likely to be successful.
Even if the vein cannot be recanalized, decompression
of the venous thoracic outlet should be performed. The
method depends on whether ancillary reconstruction
should be performed, which in turn depends on symptom
status. If symptoms are mild, decompression alone is car-
ried out by means of transaxillary first rib resection includ-
ing aggressive external venolysis and debulking of the sub-
clavius muscle and tendon. If symptoms are severe,
reconstruction is warranted. We believe medial claviculec-
tomy offers the widest exposure and most options in this
situation, but others advocate clavicular preservation.
If thrombolysis can be initiated and is successful,
subsequent treatment depends on the status of the vein.
If normal (with the arm adducted), transaxillary first rib
resection (with venolysis) is performed. No consensus
currently exists for treatment of a residual defect. We
believe that if symptoms are relatively mild, transaxillary
first rib resection is adequate. If balloon angioplasty is to
be considered, repeat venography is performed and an-
press
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severe, claviculectomy and reconstruction should be
considered.
All patients are anticoagulated for 3 to 6 months and
followed clinically and by ultrasound scans with attention
paid to the contralateral side as well. Angioplasty and
stenting should never be used in the nondecompressed
venous bony thoracic outlet, and at this point we believe
that although angioplasty is safe once the rib or clavicle has
been removed, stenting even in this situation should be
used with caution.
SUMMARY
Although the basic algorithm is generally agreed
upon, numerous questions remain and no randomized
studies exist. A partial list of questions to answer would
Fig 5. Algorithm for treatment of patients with partial o
accurately, the chances of success) is defined by the durat
outlet decompression is defined by the status of the resid
not defined in our protocol, although we believe decominclude:● Definitive outcomes with and without thoracic outlet
decompression after thrombolysis by means of a true
prospective randomized trial.
● Definitive answer to the timing of decompression –
acute or delayed?
● The role of angioplasty vs observation for residual
defects after decompression.
● The role of stents in the decompressed thoracic outlet.
● Duration of postoperative anticoagulation.
● Results after claviculectomy: functional and cosmetic
perception and reality.
● Natural history of the contralateral side.
● Long-term functional outcome – occupational and
recreational.
● Best treatment of the vein that cannot be opened with
plete effort thrombosis. The best initial procedure (more
f symptoms, whereas the subsequent method of thoracic
ein and residual symptoms. Timing of decompression is
ion should immediately follow thrombolysis.r com
ion o
ual vthrombolysis.
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method thereof.
● Cellular and molecular events at the diseased costocla-
vicular junction.
● More information on the role of hypercoagulable
states in effort thrombosis.
In addition, the problem is common enough and data
confusing and incomplete enough that a consensus state-
ment from a relevant professional society would be ex-
tremely helpful.
The current standard of care in patients with effort throm-
bosis is catheter-directed thrombolysis followed by definitive
decompression of the anterior part of the thoracic outlet
(costoclavicular junction), although proof of effectiveness of
such decompression is lacking. As Urschel et al20 pointed out
at the turn of the (21st) century, “In Paget-Schroetter syn-
drome, the earlier the diagnosis and treatment, the better the
results.” If patients are seen early after the onset of total
thrombosis (within a week or 2), results of this algorithm are
excellent, but this concept is surprisingly often violated, even
in 2009. In addition to understanding how to treat this
condition with the tools at our disposal, vascular surgeons also
need to be aware of the need to educate those who see these
patients first, including primary care physicians, emergency
room personnel, military and student health clinic personnel,
and the patients themselves. This is a problem of young,
functional adults, and thus is it unusually critical that it be
treated correctly.
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